IMGN - ImmunoGen - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ImmunoGen's activity chart (see below) currently has 127 price targets and 118 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 94.83% with an average time for these price targets to be met of 549.78 days.

Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 12-Feb-2024. First documented stock forecast 06-Aug-2012.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 12-Feb-2024

$31

$-0.23 (-0.74%)

$31

2 years 8 months 12 days ago
(12-Feb-2024)

5/6 (83.33%)

$-0.23 (-0.74%)

121

Buy Since 04-Dec-2023

$31

$-0.23 (-0.74%)

$31

2 years 10 months 20 days ago
(04-Dec-2023)

4/4 (100%)

$1.78 (6.09%)

887

Buy Since 01-Dec-2023

$31

$-0.23 (-0.74%)

2 years 10 months 23 days ago
(01-Dec-2023)

2/2 (100%)

$1.68 (5.73%)

294

Buy Since 04-Mar-2019

$25

$-6.23 (-19.95%)

2 years 10 months 23 days ago
(01-Dec-2023)

2/3 (66.67%)

$-4.32 (-14.73%)

1387

Buy Since 16-Nov-2022

$31

$-0.23 (-0.74%)

$26

2 years 10 months 23 days ago
(01-Dec-2023)

4/4 (100%)

$1.68 (5.73%)

114

Show more analysts

Please expand the browser size to see the chart

What is IMGN (ImmunoGen) average time for price targets to be met?

On average it took 550 days for the stock forecasts to be reached, with an average price target met ratio of 94.83%.

Which analyst most recently updated their price target on IMGN (ImmunoGen)?

Peter Lawson

Which analyst has the most public recommendations on IMGN (ImmunoGen)?

Peter Lawson works at BARCLAYS and has 7 price targets and 4 ratings on IMGN

Which analyst is the currently most bullish on IMGN (ImmunoGen)?

Swayampakula Ramakanth with the highest potential upside of $0.03

Which analyst is the currently most reserved on IMGN (ImmunoGen)?

Matthew Harrison with the lowest potential downside of -$29.83
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?